Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of OxyContin.

Traveling over our heads at hypersonic speeds beyond Mach 7, lies the future of spy plane technology. It can be anywhere in the world in one hour, enter any country unnoticed, and be out before their ...

The new settlement deal could net Pennsylvania and Delaware as much as $212 million and $27 million, respectively, in payouts.

A settlement was reached in principal between Purdue Pharma, the Sackler Family, states, and the victims of the opioid crisis.

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Under the newest version of the settlement, the Sacklers would only be immune from prosecution by individuals who agreed to it.

A settlement has been reached in a lawsuit, as owners of Purdue Pharma will pay billions over their role in the opioid crisis. The settlement was announced Thursday.

The ship has sailed on Indiana contending for the Big Ten title. But there are winnable games left on the schedule.

Purdue Pharma, under the leadership of the Sackler family, manufactured and sold opioids like Oxycontin for decades.

247 Sports’ Irish Illustrated confirmed that both interior lineman Pat Coogan and guard Rocco Spindler have entered the transfer portal.

The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.